The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.
about
Inhaled protein/peptide-based therapies for respiratory diseaseDirect administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platformCombination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles.Effect of formulation on the stability and aerosol performance of a nebulized antibodyDramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.High Resolution Ultrasound and Photoacoustic Imaging of Orthotopic Lung Cancer in Mice: New Perspectives for Onco-Pharmacology.Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment.VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutationsBioavailability of therapeutic proteins by inhalation--worker safety aspects.Nebulization as a delivery method for mAbs in respiratory diseases.Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab.Plasma-Derived Polyreactive Secretory-Like IgA and IgM Opsonizing Salmonella enterica Typhimurium Reduces Invasion and Gut Tissue Inflammation through Agglutination.
P2860
Q26751439-C83FAA58-D28A-4D7B-8665-A0CAB8301D15Q30374373-3E1BF397-C309-4513-9AFE-A611E508172FQ30386192-3E077C47-8C81-4005-B38F-71479C027E69Q33905993-3F34E66E-D0AA-4027-B66A-FEBC6F8234F3Q35526961-3286CD42-5A7D-4B7D-A6A1-369E8B2C0C9DQ35979621-77570DC2-1ACB-4D2F-8B41-CB1DDA44BB68Q35987173-ED550D7C-ACCD-4437-99C1-631DD9E38915Q35989939-D2A6132D-169F-4F04-8FD1-4FC54B7417CCQ36107932-4FF8B904-3571-497F-AC10-B9964F096C93Q36216197-D3FD1393-0BB9-45E1-92FE-11F94E42FFF9Q38222723-32F665E8-A24A-4638-B3E9-F0BE8D4465DBQ38306677-948923EA-9AB2-4B8A-BFB7-1F3CDCFD41AAQ38955008-CD77C653-1BC7-44BB-8522-DB40E9BD5437Q47162754-1F4FDB99-00C3-4BCA-89D1-505DBE1FA12B
P2860
The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.
@en
The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.
@nl
type
label
The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.
@en
The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.
@nl
prefLabel
The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.
@en
The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.
@nl
P2093
P2860
P50
P1476
The airways, a novel route for delivering monoclonal antibodies to treat lung tumors
@en
P2093
Agnès Maillet
Alain Le Pape
Brigitte Legrain
Christelle Parent
Dominique-Henri Douvin
Etienne Lemarié
Hervé Watier
José Hureaux
Jérôme Montharu
Laurent Guilleminault
P2860
P304
P356
10.1007/S11095-011-0442-5
P577
2011-04-14T00:00:00Z